Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 10
Submit an article Journal homepage
222
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib

Evgenii ShumilovDepartment of Haematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany;
,
Gerald WulfDepartment of Haematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany;
,
Philipp StröbelDepartment of Pathology, University Medicine Goettingen, Goettingen, Germany;
,
Justin HasenkampDepartment of Haematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany;
,
Niels HelligeDepartment of Diagnostic and Interventional Radiology, University Medicine Goettingen, Goettingen, Germany;
,
Annalen BleckmannDepartment of Haematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany;
,
Detlef HaaseDepartment of Haematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany;
,
Friederike BraulkeDepartment of Haematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany;
,
Wolfram JungDepartment of Haematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany;
,
Julie SchanzDepartment of Haematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany;
,
Mascha BinderDepartment of Oncology and Haematology, University Cancer Center Hamburg (UCCH), Hamburg, Germany
,
Lorenz TrümperDepartment of Haematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany;
&
Ulrike BacherDepartment of Haematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany; Correspondence[email protected]
 show all
Pages 2476-2480 | Received 12 Nov 2015, Accepted 23 Jan 2016, Published online: 25 Feb 2016

References

  • Advani RH, Buggy JJ, Sharman JP, et al. Bruton tyrosine kinase inhibitor ibrutinib (pci-32765) has significant activity in patients with relapsed/refractory b-cell malignancies. J Clin Oncol. 2013;31:88–94.
  • Byrd JC, Furman RR, Coutre SE, et al. Targeting btk with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369:32–42.
  • Farooqui MZ, Valdez J, Martyr S, et al. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with tp53 aberrations: a phase 2, single-arm trial. Lancet Oncol. 2015;16:169–176.
  • Tai YT, Chang BY, Kong SY, et al. Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma. Blood. 2012;120:1877–1887.
  • Edwards CM. Btk inhibition in myeloma: targeting the seed and the soil. Blood. 2012;120:1757–1759.
  • O'Brien S, Furman RR, Coutre SE, et al. Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial. Lancet Oncol. 2014;15:48–58.
  • Kough RH, Makary AZ. Chronic lymphocytic leukemia (cll) terminating in multiple myeloma: report of two cases. Blood. 1978;52:532–536.
  • Laugen RH, Carey RM, Wills MR, et al. Hypercalcemia associated with chronic lymphocytic leukemia. Arch Intern Med. 1979;139:1307–1309.
  • McMillan P, Mundy G, Mayer P. Hypercalcaemia and osteolytic bone lesions in chronic lymphocytic leukaemia. Br Med J. 1980;281:1107.
  • Redmond J, 3rd, Stites DP, Beckstead JH, et al. Chronic lymphocytic leukemia with osteolytic bone lesions, hypercalcemia, and monoclonal protein. Am J Clin Pathol. 1983;79:616–620.
  • Macintyre EA. Hypercalcaemia in chronic lymphatic leukaemia. Postgrad Med J. 1986;62:393–394.
  • Littlewood TJ, Lydon AP, Barton CJ. Hypercalcemia and osteolytic lesions associated with chronic lymphatic leukemia (cll). J Clin Pathol. 1990;43:877.
  • Seymour JF, Khouri IF, Champlin RE, et al. Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Case report and review. Am J Clin Oncol. 1994;17:360–368.
  • Briones J, Cervantes F, Montserrat E, et al. Hypercalcemia in a patient with chronic lymphocytic leukemia evolving into Richter's syndrome. Leuk Lymphoma. 1996;21:521–523.
  • Dunphy CH, Oza YV, Skelly ME. Previously undescribed form of b-cell chronic lymphoid leukemia with iga expression/secretion and lytic bone lesions. Am J Hematol. 1997;55:208–211.
  • Wright GW, Wiesenfeld D, Seymour JF. Bilateral fracture of the mandible in chronic lymphocytic leukaemia. Case report. Aust Dent J. 1997;42:20–24.
  • Robak T, Kasznicki M, Bartkowiak J, et al. Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur. Leuk Lymphoma. 2001;42:789–796.
  • Narayan H, Bandyopadhyay D, Schmidt K, et al. Successful treatment of a patient with chronic lymphocytic leukaemia (cll) presenting with bony metastases with aggressive antibody and chemotherapy. Clin Lab Haematol. 2005;27:405–408.
  • Langenberg JC, Bosman WM, van den Bremer J, et al. Pathological fractures in a patient with chronic lymphatic leukaemia without disease progression. BMJ Case Rep. 2015;2015.
  • Vij RHA, Bensinger WI, Siegel DS, et al. Ibrutinib, single agent or in combination with dexamethasone, in patients with relapsed or relapsed/refractory multiple myeloma (mm): preliminary phase 2 results. 2015. Blood(Suppl).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.